FinancialContent is the trusted provider of stock market information to the media industry.
Regeneron Pharmaceuticals Gains A Bull Ahead Of Earnings
November 03, 2017
Another Regeneron Bear is Born
October 20, 2017
Can Regeneron Hit $540?
June 30, 2017
Regeneron: Is Eylea At Risk?
June 21, 2017
Regeneron vs Amgen: Does The Patent Battle Even Matter?
June 06, 2017
Biotech Stocks: Is ASCO Much Ado About Nothing?
May 18, 2017
Another Day, Another Record Close For U.S. Stocks
February 13, 2017
Regeneron: It’s All Riding On Dupixent
February 13, 2017
Reasons To Own Regeneron In 2017; CS Sees 30% Upside
December 20, 2016
Keep An Eye On Regeneron
December 12, 2016
Here's Why Ophthotech Is Trading Down On Regeneron's News
September 30, 2016
Gilead: Hep C Prescriptions Hold at 94% Among New Patients
March 04, 2016
Regeneron Pharmaceuticals Loses 7% Following Q4 Miss
February 09, 2016
Regeneron’s 3Q EPS Beat Can’t Lift the Stock; Shares Down 4.5%
November 04, 2015
Lilly Loses Its Bloom; Amgen, Regeneron Blossom
October 12, 2015
Why Morgan Stanley Downgraded Gilead, Valeant & Regeneron
October 02, 2015
Regeneron Still Has Legs: Leerink Targets $630 a Share
August 03, 2015
Regeneron Shares Rising After Sanofi Collaboration Revealed: Good News For Shareholders?
July 28, 2015
Regeneron: Here‘s Your Next $12,000 Wonder Drug
July 24, 2015
Why Is Amgen Rising And Regeneron Falling?
June 11, 2015
The Fight Against Cholesterol Heats Up; FDA Panel Considers Drugs from Regeneron, Amgen Next Week
June 05, 2015
UPDATE: Barclays Initiates Coverage On Regeneron
January 06, 2015
Dow, S&P Creep Higher; Close at New Record
November 11, 2014
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial